import{r as i,j as e,V as g,b as h,d,E as O,S as k}from"./index-4Ly-s4cr.js";import{R as z}from"./refresh-cw-Da3gWcAr.js";import{A as u}from"./award-DlUWBS0k.js";import{A as v}from"./arrow-right-Dhrftuj8.js";import{C as q}from"./circle-check-big-DzqNVPmE.js";import{S as y}from"./star-2cVrOGT9.js";import{G as B}from"./globe-DjaafeDq.js";const V=()=>{const[r,b]=i.useState("protocols"),[j,f]=i.useState([]),[N,C]=i.useState([]),[w,m]=i.useState(!0),[n,S]=i.useState(""),[l,P]=i.useState("all"),[c,L]=i.useState("all"),[t,x]=i.useState(null);i.useEffect(()=>{E()},[]);const E=()=>{m(!0),setTimeout(()=>{C([{id:"nccn",name:"National Comprehensive Cancer Network",abbreviation:"NCCN",description:"Leading cancer treatment guidelines organization",website:"https://www.nccn.org",credibility:95,specialties:["Oncology","Hematology"],lastSync:"2024-01-20T08:00:00Z"},{id:"asco",name:"American Society of Clinical Oncology",abbreviation:"ASCO",description:"Premier oncology professional organization",website:"https://www.asco.org",credibility:94,specialties:["Oncology","Clinical Research"],lastSync:"2024-01-19T10:00:00Z"},{id:"esmo",name:"European Society for Medical Oncology",abbreviation:"ESMO",description:"Leading European oncology organization",website:"https://www.esmo.org",credibility:92,specialties:["Oncology","Molecular Medicine"],lastSync:"2024-01-18T14:00:00Z"}]),f([{id:"nccn-breast-2024",title:"NCCN Guidelines for Breast Cancer Treatment",description:"Comprehensive evidence-based guidelines for breast cancer diagnosis, treatment, and follow-up care",category:"Treatment Guidelines",subcategory:"Breast Cancer",evidenceLevel:"A",lastUpdated:"2024-01-15T00:00:00Z",version:"1.2024",organization:"NCCN",cancerTypes:["Breast Cancer","Invasive Ductal Carcinoma","Lobular Carcinoma"],treatmentPhase:["Diagnosis","Primary Treatment","Adjuvant","Metastatic"],ageGroups:["Adult","Elderly"],evidenceGrade:"Category 1",status:"active",tags:["chemotherapy","immunotherapy","targeted-therapy","surgery"],recommendations:[{id:"rec-001",level:"strong",statement:"HER2 testing should be performed on all invasive breast cancers",rationale:"HER2 status determines eligibility for targeted therapy with trastuzumab",evidenceSummary:"Multiple randomized controlled trials demonstrate improved outcomes with HER2-targeted therapy",implementation:"Use FDA-approved assays (IHC or FISH) in certified laboratories",contraindications:[],considerations:["Quality assurance requirements","Turnaround time impact on treatment"]},{id:"rec-002",level:"strong",statement:"Neoadjuvant chemotherapy is preferred for locally advanced breast cancer",rationale:"Allows for downstaging and assessment of treatment response",evidenceSummary:"Phase III trials show equivalent survival with improved surgical outcomes",implementation:"Multidisciplinary team evaluation required before treatment initiation",contraindications:["T1N0 disease","Contraindications to chemotherapy"],considerations:["Patient preference","Fertility preservation needs"]}],references:[{id:"ref-001",type:"clinical-trial",title:"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer",authors:"Piccart-Gebhart MJ, et al.",journal:"N Engl J Med",year:2005,pmid:"16236738",doi:"10.1056/NEJMoa052306",evidenceQuality:"high",relevanceScore:95},{id:"ref-002",type:"meta-analysis",title:"Neoadjuvant chemotherapy in breast cancer: a meta-analysis of randomized trials",authors:"Mauri D, et al.",journal:"J Natl Cancer Inst",year:2005,pmid:"16249345",doi:"10.1093/jnci/dji315",evidenceQuality:"high",relevanceScore:88}],implementation:{prerequisites:["Multidisciplinary team available","Pathology services","Imaging capabilities"],contraindications:["Active infection","Severe comorbidities","Patient refusal"],monitoringRequirements:["CBC with differential","Comprehensive metabolic panel","ECHO/MUGA"],expectedOutcomes:["Improved overall survival","Disease-free survival improvement"],commonChallenges:["Patient compliance","Side effect management","Drug availability"],bestPractices:["Regular team meetings","Patient education","Symptom monitoring"]},metrics:{adoptionRate:87,outcomeImprovement:23,safetyProfile:92,costEffectiveness:"Cost-effective",patientSatisfaction:89,clinicianFeedback:91}},{id:"asco-lung-2024",title:"ASCO Guidelines for Non-Small Cell Lung Cancer",description:"Evidence-based recommendations for NSCLC treatment across all stages",category:"Treatment Guidelines",subcategory:"Lung Cancer",evidenceLevel:"A",lastUpdated:"2024-01-10T00:00:00Z",version:"2024.1",organization:"ASCO",cancerTypes:["Non-Small Cell Lung Cancer","Adenocarcinoma","Squamous Cell Carcinoma"],treatmentPhase:["Screening","Diagnosis","Treatment","Surveillance"],ageGroups:["Adult","Elderly"],evidenceGrade:"Strong Recommendation",status:"active",tags:["immunotherapy","targeted-therapy","biomarkers","precision-medicine"],recommendations:[{id:"rec-003",level:"strong",statement:"PD-L1 testing should be performed on all advanced NSCLC specimens",rationale:"PD-L1 expression predicts response to immune checkpoint inhibitors",evidenceSummary:"Multiple phase III trials demonstrate improved outcomes with PD-1/PD-L1 inhibitors",implementation:"Use validated PD-L1 assays with appropriate scoring algorithms",contraindications:["Insufficient tissue","Poor specimen quality"],considerations:["Test turnaround time","Laboratory certification requirements"]}],references:[{id:"ref-003",type:"clinical-trial",title:"Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer",authors:"Reck M, et al.",journal:"N Engl J Med",year:2016,pmid:"27718847",doi:"10.1056/NEJMoa1606774",evidenceQuality:"high",relevanceScore:94}],implementation:{prerequisites:["Molecular testing capabilities","Immunotherapy administration facilities"],contraindications:["Autoimmune disease","Immunosuppressive therapy"],monitoringRequirements:["Immune-related adverse events monitoring","Tumor response assessment"],expectedOutcomes:["Improved progression-free survival","Overall survival benefit"],commonChallenges:["Immune-related toxicities","Cost considerations"],bestPractices:["Early toxicity recognition","Patient education on side effects"]},metrics:{adoptionRate:82,outcomeImprovement:31,safetyProfile:85,costEffectiveness:"High-value",patientSatisfaction:86,clinicianFeedback:88}},{id:"esmo-crc-2024",title:"ESMO Clinical Practice Guidelines for Colorectal Cancer",description:"Comprehensive guidelines for colorectal cancer management from diagnosis to survivorship",category:"Treatment Guidelines",subcategory:"Colorectal Cancer",evidenceLevel:"A",lastUpdated:"2024-01-08T00:00:00Z",version:"2024",organization:"ESMO",cancerTypes:["Colorectal Cancer","Colon Cancer","Rectal Cancer"],treatmentPhase:["Screening","Diagnosis","Surgery","Adjuvant","Metastatic"],ageGroups:["Adult","Elderly"],evidenceGrade:"Level I Evidence",status:"active",tags:["microsatellite-instability","targeted-therapy","liver-resection"],recommendations:[{id:"rec-004",level:"strong",statement:"MSI testing should be performed on all colorectal cancers",rationale:"MSI-H tumors have different prognosis and treatment response patterns",evidenceSummary:"MSI status predicts response to immunotherapy and adjuvant chemotherapy benefit",implementation:"Use PCR or NGS-based MSI testing or MMR protein IHC",contraindications:[],considerations:["Cost-effectiveness","Test availability"]}],references:[{id:"ref-004",type:"guideline",title:"Metastatic colorectal cancer: ESMO Clinical Practice Guidelines",authors:"Cervantes A, et al.",journal:"Ann Oncol",year:2023,pmid:"37076135",doi:"10.1016/j.annonc.2023.03.018",evidenceQuality:"high",relevanceScore:96}],implementation:{prerequisites:["Molecular testing laboratory","Multidisciplinary team"],contraindications:["Palliative care only","Poor performance status"],monitoringRequirements:["CEA levels","Imaging studies","Toxicity assessment"],expectedOutcomes:["Improved survival","Quality of life preservation"],commonChallenges:["Treatment sequencing","Resistance development"],bestPractices:["Regular tumor board review","Patient-centered care"]},metrics:{adoptionRate:79,outcomeImprovement:28,safetyProfile:88,costEffectiveness:"Cost-effective",patientSatisfaction:84,clinicianFeedback:87}}]),m(!1)},1e3)},I=j.filter(s=>{const a=s.title.toLowerCase().includes(n.toLowerCase())||s.description.toLowerCase().includes(n.toLowerCase())||s.tags.some(G=>G.toLowerCase().includes(n.toLowerCase())),o=l==="all"||s.category===l,R=c==="all"||s.evidenceLevel===c;return a&&o&&R}),p=s=>{switch(s){case"A":return"bg-green-100 text-green-800";case"B":return"bg-blue-100 text-blue-800";case"C":return"bg-yellow-100 text-yellow-800";case"D":return"bg-orange-100 text-orange-800";default:return"bg-gray-100 text-gray-800"}},T=s=>{switch(s){case"strong":return"bg-green-100 text-green-800";case"moderate":return"bg-yellow-100 text-yellow-800";case"weak":return"bg-orange-100 text-orange-800";default:return"bg-gray-100 text-gray-800"}},A=()=>e.jsxs("div",{className:"space-y-6",children:[e.jsx("div",{className:"bg-white rounded-lg border border-gray-200 p-4",children:e.jsxs("div",{className:"flex flex-wrap gap-4",children:[e.jsx("div",{className:"flex-1 min-w-64",children:e.jsxs("div",{className:"relative",children:[e.jsx(k,{className:"absolute left-3 top-1/2 transform -translate-y-1/2 w-4 h-4 text-gray-400"}),e.jsx("input",{type:"text",placeholder:"Search protocols, guidelines, or treatments...",value:n,onChange:s=>S(s.target.value),className:"w-full pl-10 pr-4 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-transparent"})]})}),e.jsxs("select",{value:l,onChange:s=>P(s.target.value),className:"px-4 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-transparent",children:[e.jsx("option",{value:"all",children:"All Categories"}),e.jsx("option",{value:"Treatment Guidelines",children:"Treatment Guidelines"}),e.jsx("option",{value:"Diagnostic Protocols",children:"Diagnostic Protocols"}),e.jsx("option",{value:"Safety Guidelines",children:"Safety Guidelines"})]}),e.jsxs("select",{value:c,onChange:s=>L(s.target.value),className:"px-4 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-transparent",children:[e.jsx("option",{value:"all",children:"All Evidence Levels"}),e.jsx("option",{value:"A",children:"Level A (Highest)"}),e.jsx("option",{value:"B",children:"Level B (High)"}),e.jsx("option",{value:"C",children:"Level C (Moderate)"}),e.jsx("option",{value:"D",children:"Level D (Low)"})]})]})}),e.jsx("div",{className:"grid grid-cols-1 lg:grid-cols-2 xl:grid-cols-3 gap-6",children:I.map(s=>e.jsx("div",{className:"bg-white rounded-lg border border-gray-200 hover:shadow-lg transition-shadow",children:e.jsxs("div",{className:"p-6",children:[e.jsx("div",{className:"flex items-start justify-between mb-4",children:e.jsxs("div",{className:"flex-1",children:[e.jsxs("div",{className:"flex items-center space-x-2 mb-2",children:[e.jsxs("span",{className:`inline-flex px-2 py-1 text-xs font-semibold rounded-full ${p(s.evidenceLevel)}`,children:["Level ",s.evidenceLevel]}),e.jsx("span",{className:"text-xs text-gray-500",children:s.organization})]}),e.jsx("h3",{className:"text-lg font-semibold text-gray-900 mb-2",children:s.title}),e.jsx("p",{className:"text-sm text-gray-600 mb-3",children:s.description})]})}),e.jsxs("div",{className:"space-y-3",children:[e.jsxs("div",{children:[e.jsx("p",{className:"text-xs text-gray-500 mb-1",children:"Cancer Types"}),e.jsxs("div",{className:"flex flex-wrap gap-1",children:[s.cancerTypes.slice(0,2).map(a=>e.jsx("span",{className:"inline-flex px-2 py-1 text-xs bg-blue-100 text-blue-800 rounded",children:a},a)),s.cancerTypes.length>2&&e.jsxs("span",{className:"text-xs text-gray-500",children:["+",s.cancerTypes.length-2," more"]})]})]}),e.jsxs("div",{className:"flex items-center justify-between text-sm",children:[e.jsxs("div",{className:"flex items-center space-x-4",children:[e.jsxs("div",{className:"flex items-center space-x-1",children:[e.jsx(y,{className:"w-4 h-4 text-yellow-500"}),e.jsxs("span",{className:"text-gray-600",children:[s.metrics.adoptionRate,"%"]})]}),e.jsxs("div",{className:"flex items-center space-x-1",children:[e.jsx(d,{className:"w-4 h-4 text-green-500"}),e.jsxs("span",{className:"text-gray-600",children:["+",s.metrics.outcomeImprovement,"%"]})]})]}),e.jsxs("span",{className:"text-xs text-gray-500",children:["Updated ",new Date(s.lastUpdated).toLocaleDateString()]})]}),e.jsxs("div",{className:"flex items-center justify-between pt-3 border-t border-gray-100",children:[e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsxs("span",{className:"text-xs text-gray-500",children:[s.recommendations.length," recommendations"]}),e.jsx("span",{className:"text-xs text-gray-400",children:"•"}),e.jsxs("span",{className:"text-xs text-gray-500",children:[s.references.length," references"]})]}),e.jsxs("button",{onClick:()=>x(s),className:"flex items-center space-x-1 px-3 py-1 text-sm text-blue-600 hover:bg-blue-50 rounded-lg transition-colors",children:[e.jsx("span",{children:"View Details"}),e.jsx(v,{className:"w-3 h-3"})]})]})]})]})},s.id))})]}),M=()=>t?e.jsxs("div",{className:"space-y-6",children:[e.jsxs("button",{onClick:()=>x(null),className:"flex items-center space-x-2 text-blue-600 hover:text-blue-800",children:[e.jsx(v,{className:"w-4 h-4 transform rotate-180"}),e.jsx("span",{children:"Back to Protocols"})]}),e.jsxs("div",{className:"bg-white rounded-lg border border-gray-200 p-6",children:[e.jsx("div",{className:"flex items-start justify-between mb-4",children:e.jsxs("div",{children:[e.jsxs("div",{className:"flex items-center space-x-3 mb-2",children:[e.jsxs("span",{className:`inline-flex px-3 py-1 text-sm font-semibold rounded-full ${p(t.evidenceLevel)}`,children:["Evidence Level ",t.evidenceLevel]}),e.jsx("span",{className:"inline-flex px-3 py-1 text-sm bg-blue-100 text-blue-800 rounded-full",children:t.organization}),e.jsxs("span",{className:"text-sm text-gray-500",children:["Version ",t.version]})]}),e.jsx("h1",{className:"text-2xl font-bold text-gray-900 mb-2",children:t.title}),e.jsx("p",{className:"text-gray-600",children:t.description})]})}),e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-6 mt-6",children:[e.jsxs("div",{children:[e.jsx("h4",{className:"text-sm font-medium text-gray-900 mb-2",children:"Cancer Types"}),e.jsx("div",{className:"space-y-1",children:t.cancerTypes.map(s=>e.jsx("span",{className:"block text-sm text-gray-600",children:s},s))})]}),e.jsxs("div",{children:[e.jsx("h4",{className:"text-sm font-medium text-gray-900 mb-2",children:"Treatment Phases"}),e.jsx("div",{className:"space-y-1",children:t.treatmentPhase.map(s=>e.jsx("span",{className:"block text-sm text-gray-600",children:s},s))})]}),e.jsxs("div",{children:[e.jsx("h4",{className:"text-sm font-medium text-gray-900 mb-2",children:"Key Metrics"}),e.jsxs("div",{className:"space-y-1",children:[e.jsxs("div",{className:"text-sm text-gray-600",children:["Adoption: ",t.metrics.adoptionRate,"%"]}),e.jsxs("div",{className:"text-sm text-gray-600",children:["Improvement: +",t.metrics.outcomeImprovement,"%"]}),e.jsxs("div",{className:"text-sm text-gray-600",children:["Safety: ",t.metrics.safetyProfile,"%"]})]})]})]})]}),e.jsxs("div",{className:"bg-white rounded-lg border border-gray-200",children:[e.jsx("div",{className:"px-6 py-4 border-b border-gray-200",children:e.jsx("h3",{className:"text-lg font-semibold text-gray-900",children:"Clinical Recommendations"})}),e.jsx("div",{className:"p-6 space-y-6",children:t.recommendations.map(s=>e.jsxs("div",{className:"border border-gray-200 rounded-lg p-4",children:[e.jsx("div",{className:"flex items-start justify-between mb-3",children:e.jsxs("div",{className:"flex-1",children:[e.jsx("div",{className:"flex items-center space-x-2 mb-2",children:e.jsxs("span",{className:`inline-flex px-2 py-1 text-xs font-semibold rounded-full ${T(s.level)}`,children:[s.level," recommendation"]})}),e.jsx("h4",{className:"text-base font-medium text-gray-900 mb-2",children:s.statement}),e.jsx("p",{className:"text-sm text-gray-600 mb-3",children:s.rationale})]})}),e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4 text-sm",children:[e.jsxs("div",{children:[e.jsx("h5",{className:"font-medium text-gray-900 mb-1",children:"Implementation"}),e.jsx("p",{className:"text-gray-600",children:s.implementation})]}),e.jsxs("div",{children:[e.jsx("h5",{className:"font-medium text-gray-900 mb-1",children:"Evidence Summary"}),e.jsx("p",{className:"text-gray-600",children:s.evidenceSummary})]})]}),s.contraindications.length>0&&e.jsxs("div",{className:"mt-3 p-3 bg-red-50 rounded-lg",children:[e.jsx("h5",{className:"text-sm font-medium text-red-900 mb-1",children:"Contraindications"}),e.jsx("ul",{className:"text-sm text-red-700 space-y-1",children:s.contraindications.map((a,o)=>e.jsxs("li",{children:["• ",a]},o))})]})]},s.id))})]}),e.jsxs("div",{className:"bg-white rounded-lg border border-gray-200",children:[e.jsx("div",{className:"px-6 py-4 border-b border-gray-200",children:e.jsx("h3",{className:"text-lg font-semibold text-gray-900",children:"Implementation Guidance"})}),e.jsx("div",{className:"p-6",children:e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-6",children:[e.jsxs("div",{children:[e.jsx("h4",{className:"text-sm font-medium text-gray-900 mb-3",children:"Prerequisites"}),e.jsx("ul",{className:"space-y-2 text-sm text-gray-600",children:t.implementation.prerequisites.map((s,a)=>e.jsxs("li",{className:"flex items-start space-x-2",children:[e.jsx(q,{className:"w-4 h-4 text-green-500 mt-0.5 flex-shrink-0"}),e.jsx("span",{children:s})]},a))})]}),e.jsxs("div",{children:[e.jsx("h4",{className:"text-sm font-medium text-gray-900 mb-3",children:"Best Practices"}),e.jsx("ul",{className:"space-y-2 text-sm text-gray-600",children:t.implementation.bestPractices.map((s,a)=>e.jsxs("li",{className:"flex items-start space-x-2",children:[e.jsx(y,{className:"w-4 h-4 text-yellow-500 mt-0.5 flex-shrink-0"}),e.jsx("span",{children:s})]},a))})]})]})})]}),e.jsxs("div",{className:"bg-white rounded-lg border border-gray-200",children:[e.jsx("div",{className:"px-6 py-4 border-b border-gray-200",children:e.jsx("h3",{className:"text-lg font-semibold text-gray-900",children:"Supporting Evidence"})}),e.jsx("div",{className:"p-6 space-y-4",children:t.references.map(s=>e.jsx("div",{className:"border border-gray-200 rounded-lg p-4",children:e.jsxs("div",{className:"flex items-start justify-between",children:[e.jsxs("div",{className:"flex-1",children:[e.jsxs("div",{className:"flex items-center space-x-2 mb-2",children:[e.jsxs("span",{className:`inline-flex px-2 py-1 text-xs font-semibold rounded-full ${s.evidenceQuality==="high"?"bg-green-100 text-green-800":s.evidenceQuality==="moderate"?"bg-yellow-100 text-yellow-800":"bg-orange-100 text-orange-800"}`,children:[s.evidenceQuality," quality"]}),e.jsx("span",{className:"inline-flex px-2 py-1 text-xs bg-blue-100 text-blue-800 rounded-full",children:s.type.replace("-"," ")}),e.jsxs("span",{className:"text-xs text-gray-500",children:["Relevance: ",s.relevanceScore,"%"]})]}),e.jsx("h4",{className:"text-sm font-medium text-gray-900 mb-1",children:s.title}),e.jsxs("p",{className:"text-sm text-gray-600",children:[s.authors," • ",s.journal," • ",s.year]}),s.pmid&&e.jsxs("div",{className:"flex items-center space-x-2 mt-2",children:[e.jsxs("span",{className:"text-xs text-gray-500",children:["PMID: ",s.pmid]}),s.doi&&e.jsxs("span",{className:"text-xs text-gray-500",children:["DOI: ",s.doi]})]})]}),e.jsx(O,{className:"w-4 h-4 text-gray-400"})]})},s.id))})]})]}):null,D=()=>e.jsx("div",{className:"space-y-6",children:e.jsx("div",{className:"grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6",children:N.map(s=>e.jsxs("div",{className:"bg-white rounded-lg border border-gray-200 p-6",children:[e.jsxs("div",{className:"flex items-start justify-between mb-4",children:[e.jsxs("div",{children:[e.jsx("h3",{className:"text-lg font-semibold text-gray-900",children:s.abbreviation}),e.jsx("p",{className:"text-sm text-gray-600 mt-1",children:s.name})]}),e.jsxs("div",{className:"flex items-center space-x-1",children:[e.jsx(u,{className:"w-4 h-4 text-yellow-500"}),e.jsxs("span",{className:"text-sm font-medium text-gray-900",children:[s.credibility,"%"]})]})]}),e.jsx("p",{className:"text-sm text-gray-600 mb-4",children:s.description}),e.jsxs("div",{className:"space-y-2",children:[e.jsxs("div",{children:[e.jsx("h4",{className:"text-xs font-medium text-gray-900 mb-1",children:"Specialties"}),e.jsx("div",{className:"flex flex-wrap gap-1",children:s.specialties.map(a=>e.jsx("span",{className:"inline-flex px-2 py-1 text-xs bg-blue-100 text-blue-800 rounded",children:a},a))})]}),e.jsxs("div",{className:"flex items-center justify-between text-xs text-gray-500 pt-2 border-t border-gray-100",children:[e.jsxs("span",{children:["Last sync: ",new Date(s.lastSync).toLocaleDateString()]}),e.jsxs("a",{href:s.website,target:"_blank",rel:"noopener noreferrer",className:"flex items-center space-x-1 text-blue-600 hover:text-blue-800",children:[e.jsx(B,{className:"w-3 h-3"}),e.jsx("span",{children:"Website"})]})]})]})]},s.id))})});return w?e.jsx("div",{className:"flex items-center justify-center h-64",children:e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(z,{className:"w-6 h-6 animate-spin text-blue-600"}),e.jsx("span",{className:"text-gray-600",children:"Loading evidence-based protocols..."})]})}):e.jsxs("div",{className:"max-w-7xl mx-auto p-6",children:[e.jsx("div",{className:"mb-8",children:e.jsxs("div",{className:"flex items-center space-x-3 mb-4",children:[e.jsx("div",{className:"p-2 bg-green-100 rounded-lg",children:e.jsx(g,{className:"w-6 h-6 text-green-600"})}),e.jsxs("div",{children:[e.jsx("h1",{className:"text-2xl font-bold text-gray-900",children:"Evidence-Based Clinical Protocols"}),e.jsx("p",{className:"text-gray-600",children:"Access current, evidence-based treatment guidelines from leading organizations"})]})]})}),t?M():e.jsxs(e.Fragment,{children:[e.jsx("div",{className:"border-b border-gray-200 mb-6",children:e.jsx("nav",{className:"-mb-px flex space-x-8",children:[{id:"protocols",label:"Protocols",icon:g},{id:"organizations",label:"Organizations",icon:u},{id:"implementation",label:"Implementation",icon:h},{id:"analytics",label:"Analytics",icon:d}].map(s=>{const a=s.icon;return e.jsxs("button",{onClick:()=>b(s.id),className:`flex items-center space-x-2 py-2 px-1 border-b-2 font-medium text-sm ${r===s.id?"border-green-500 text-green-600":"border-transparent text-gray-500 hover:text-gray-700 hover:border-gray-300"}`,children:[e.jsx(a,{className:"w-4 h-4"}),e.jsx("span",{children:s.label})]},s.id)})})}),r==="protocols"&&A(),r==="organizations"&&D(),r==="implementation"&&e.jsxs("div",{className:"text-center py-12",children:[e.jsx(h,{className:"w-16 h-16 text-gray-400 mx-auto mb-4"}),e.jsx("h3",{className:"text-lg font-medium text-gray-900 mb-2",children:"Implementation Tools"}),e.jsx("p",{className:"text-gray-600",children:"Implementation checklists and monitoring tools will be available here."})]}),r==="analytics"&&e.jsxs("div",{className:"text-center py-12",children:[e.jsx(d,{className:"w-16 h-16 text-gray-400 mx-auto mb-4"}),e.jsx("h3",{className:"text-lg font-medium text-gray-900 mb-2",children:"Protocol Analytics"}),e.jsx("p",{className:"text-gray-600",children:"Usage analytics and outcome tracking will be displayed here."})]})]})]})};export{V as default};
//# sourceMappingURL=EvidenceBasedProtocolsSystem-Dw_rA5sQ.js.map
